About Ipca Laboratories Ltd
Ipca Laboratories is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharmaceutical ingredients (APIs).
Founded
1949
CEO
Premchand Godha
Employees
23,467
HQ
Mumbai, India
Finished Products
1Sale of Products
₹20,014.67Cr2Export Incentive
₹52.25Cr3Scrap Sale
₹50.09Cr4Sale of Services
₹42.20Cr5Miscellaneous Income
₹20.24Cr6Sundry Balances W/back
₹1.68CrRaw Materials
1Raw Materials Consumed
₹3,950.22Cr2Formulations
₹993.86Cr3Packing Materials
₹803.50Cr4Active Pharma.Ingredients/Inte
₹47.10Cr5Neutralisation of Duties & Tax
₹-79.39CrAbout Ipca Laboratories Ltd
Ipca Laboratories is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharmaceutical ingredients (APIs).
Founded:1949
CEO:Premchand Godha
Employees:23,467
HQ:Mumbai, India
Finished Products
1Sale of Products
₹20,014.67Cr2Export Incentive
₹52.25Cr3Scrap Sale
₹50.09Cr4Sale of Services
₹42.20Cr5Miscellaneous Income
₹20.24Cr6Sundry Balances W/back
₹1.68CrRaw Materials
1Raw Materials Consumed
₹3,950.22Cr2Formulations
₹993.86Cr3Packing Materials
₹803.50Cr4Active Pharma.Ingredients/Inte
₹47.10Cr5Neutralisation of Duties & Tax
₹-79.39CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹2,002
52W Low
₹1,252
Volume161.65K
Avg VolumeN/A
Beta0.05
Dividend Yield0.31%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
36.10x
Valuation
P/B Ratio
6.16x
Valuation
EPS
₹54.20
Valuation
Dividend Yield
0.31%
Valuation
ROE
14.15%
Profitability
ROCE
18.58%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
45.5%
International
54.5%
Outside India54.5%
India45.5%
Strategic Relations
Collaborations, joint ventures & subsidiaries
C
Central Drug Research Institute
India
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.10x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
7.8%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.